Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Ned Tijdschr Geneeskd ; 1662022 03 10.
Article in Dutch | MEDLINE | ID: mdl-35499546

ABSTRACT

An 8-year-old girl with a lingual thyroid was evaluated because of a tumor at the base of the tongue. Ultrasound showed a hypoechogenic homogeneous parenchymatous structure at the base of the tongue consistent with thyroid tissue. Suboptimal levothyroxine treatment resulted in longstanding TSH stimulation causing a lingual goiter.


Subject(s)
Tongue Neoplasms , Tongue , Child , Female , Humans , Thyroid Gland , Thyroxine/therapeutic use , Tongue Neoplasms/diagnosis , Ultrasonography
2.
Rom J Intern Med ; 54(2): 98-104, 2016.
Article in English | MEDLINE | ID: mdl-27352438

ABSTRACT

From an oncological perspective, the second most common malignancies in children are brain tumors. Despite the recent therapeutic breakthroughs in this field, concerning surgery, radiotherapy and chemotherapy alike, some cases still have poor outcomes in curability. This is especially the case in patients with high-risk histological types of tumors, and those suffering from residual, remitting and disseminated diseases. Due to the unique neuroanatomical emplacement of brain tumors and their aggressive infiltrative behavior, their total removal remains a demanding task. This can be perceived in the high rates of failure treatment and disease recurrence. Furthermore, the adjacent healthy brain tissue is inevitably damaged in the surgical process of effectively removing these tumors. Thus, stem cell transplantation may be a viable solution for the clinical management of these malignancies, as proven by various recent breakthroughs. In the current concise review, we present the role of next generation sequencing in HLA typing for stem cell transplantation in primary CNS pediatric malignancies.


Subject(s)
Brain Neoplasms/genetics , Brain Neoplasms/surgery , Genotype , Histocompatibility Testing , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/surgery , Stem Cell Transplantation , Alleles , Brain Neoplasms/pathology , Child , Evidence-Based Medicine , Histocompatibility Testing/methods , Humans , Neoplasm Invasiveness , Neoplasm Recurrence, Local/pathology , Stem Cell Transplantation/methods , Treatment Outcome
3.
Chirurgia (Bucur) ; 110(3): 262-7, 2015.
Article in English | MEDLINE | ID: mdl-26158736

ABSTRACT

PURPOSE: To evaluate the potentials of T2 weighted (T2W)MRI and diffusion weighted (DW) MRI for prostate cancer(PCa) detection, local staging and treatment planning in high-risk group. MATERIAL AND METHODS: Endorectal MRI was performed in 17 Romanian men (median age: 66 years; range: 58 75 years), prostate specific antigen (PSA) serum levels (median: 20 ng mL; range: 8.6 100 ng mL) with positive findings for PCa(median Gleason score: 8; range: 7 - 9). Imaging findings were compared to standarised 20-core transperineal saturation biopsy. The prostate was divided into 16 standart sectors(10 posterior and 6 anterior). RESULTS: Overall, prostate cancer was detected in 16 patients(94%) on DW-MRI alone and in all 17 patients (100%) on T2W-MRI alone, and on combined imaging. On T2W-MRI165 sectors out of 272 were suspicious for PCa and 124 (75%)were cancer positive. On DW-MRI 126 sectors out of 272 were suspicious for PCa and 118 (95%) were cancer positive. On the combined imaging approach 134 sectors out of 272 were suspicious for PCa and 126 (94%) were cancer positive. This resulted in diagnostic accuracies per sector of 76% for T2WMRI, 86% for DW-MRI and 89% for combined imaging. Multifocal PCa was confirmed both on MR imaging and by biopsy in 8 of the 17 men (47%) Extra capsular extension(ECE) or seminal vesicles invasion (SVI) was highly suspected in 8 (47%) respectively 7 (41%) of the 17 patients. 6 patients(35%) presented both ECE and SVI. MRI findings were taken into account for treatment planning and none of these patients underwent radical prostatectomy and instead was treated with palliative cryotherapy, radiotherapy and hormone therapy. CONCLUSIONS: Endorectal MRI is highly accurate in PCa detection in the high-risk group and seems to have an important role in local staging and treatment planning for Romanian population.


Subject(s)
Biomarkers, Tumor/blood , Biopsy , Magnetic Resonance Imaging/methods , Prostate-Specific Antigen/blood , Prostatic Neoplasms/pathology , Aged , Biopsy/methods , Cryotherapy/methods , Endosonography , Humans , Male , Middle Aged , Neoplasm Staging , Palliative Care/methods , Predictive Value of Tests , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/therapy , Radiotherapy, Adjuvant/methods , Rectum , Retrospective Studies , Risk Assessment , Risk Factors , Romania , Sensitivity and Specificity , Severity of Illness Index , Treatment Outcome
4.
Inflamm Bowel Dis ; 16(10): 1669-77, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20127995

ABSTRACT

BACKGROUND: This study was designed to elucidate the contribution of parental height to the stature of children with inflammatory bowel disease (IBD), who often exhibit growth impairment. Accordingly, we compared patients' final adult heights and target heights based on measured parental heights and examined predictors of final adult height in pediatric IBD patients. METHODS: We prospectively analyzed the growth of 295 patients diagnosed between ages 1 and 18 (211 Crohn's disease [CD], 84 ulcerative colitis [UC]) and their family members (283 mothers, 231 fathers, 55 siblings). RESULTS: Twenty-two percent had growth impairment (height for age Z-score <-1.64, equivalent to <5th percentile on growth curve) in more than 1 measurement since diagnosis; most growth-impaired patients had CD (88% CD versus 12% UC). Parents of the growth-impaired group had lower mean height Z-scores compared to parents of nongrowth-impaired patients (-0.67 versus 0.02 for mothers [P < 0.001]; -0.31 versus 0.22 for fathers [P = 0.002]). For 108 patients who reached adult heights and had available parental heights, the growth-impaired group continued to demonstrate lower adult height Z-scores (-1.38 versus 0.07; P < 0.001). Adult heights were within 1 SD of target heights even for the growth-impaired group. Only 11.3% remained persistently growth-impaired in adulthood. Multivariate regression analysis demonstrated lower parental height and minimum patient height Z-score as significant predictors of lower final adult height in IBD. CONCLUSIONS: Parental height is a powerful determinant of linear growth even in the presence of chronic inflammation, and should be an integral part of the evaluation of growth in IBD children.


Subject(s)
Body Height/physiology , Colitis, Ulcerative/physiopathology , Crohn Disease/physiopathology , Growth Disorders/physiopathology , Parents , Adolescent , Adult , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Prognosis , Prospective Studies , Siblings , Statistics, Nonparametric , Young Adult
5.
Chirurgia (Bucur) ; 103(1): 61-6, 2008.
Article in Romanian | MEDLINE | ID: mdl-18459499

ABSTRACT

INTRODUCTION: The manner to extract the specimen after retro-peritoneoscopic nephroureterectomy varies to different surgical teams. The aim of the surgeon is to extract the specimen with minimum parietal injuries, according with oncologic principles. The objective of our study was to evaluate the ilio-inguinal approach to extract the specimen after retro-peritoneoscopic nephroureterectomy. MATERIAL AND METHOD: Evaluation and follow-up of 71 patients with retroperitoneoscopic nephroureterectomy for urothelial cancer (65 pelvic urothelial carcinoma and 6 urothelial carcinoma of the ureter). Ilio-inguinal incision was used for 68 patients to extract the specimen. RESULTS: The operating time was 110 +/- 47 min. Blood lost 101 +/- 57 ml. Retroperitoneoscopic approach 10 +/- 4 min. Ilio-inguinal approach 25 +/- 10 min. The weight of the specimen was 601 +/- 127g. Tumor dimension was 5.9 +/- 1.9 cm. No conversion to open surgery was made. No late post surgery complications were registered ( follow-up at 2 and 6 months). CONCLUSIONS: The enlarged nephroureterectomy can be performed using retroperitoneoscopic approach and the specimen can be extracted through an incision at iliac fossa. This approach can be used to extract large specimens preserving the esthetic laparoscopic benefit as well as the oncologic salty and reducing the risk of post-operative eventration.


Subject(s)
Inguinal Canal , Laparoscopy , Nephrectomy/methods , Retroperitoneal Space/surgery , Ureter/surgery , Urologic Neoplasms/surgery , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
6.
Transplant Proc ; 36(2 Suppl): 177S-180S, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15041332

ABSTRACT

INTRODUCTION: From 1983 to 1996 therapy with cyclosporine in association with low-dose azathioprine and prednisone has been used for transplantation immunosuppression. The aim of our study was to present 10 years experience with cyclosporine. MATERIAL AND METHOD: Among 479 renal transplants performed since 1992, 61 were performed with cadaver donor grafts and 58 in pediatric recipients. From 1992 to 1998, the immunosuppressive protocol included CsA, azathioprine, and prednisone. Since 1998, mycophenolate mofetil (MMF) replaced azathioprine. In 2002, tacrolimus and rapamycin were introduced into our protocols. The patients were assessed in terms of serum creatinine, incidence of acute rejection, cyclosporine side effects, and graft and patient survivals. RESULTS: Five-year patient and graft survivals were higher among recipients receiving CsA-MMF-prednisone when compared with CsA-azathioprine-prednisone. The incidence of acute rejection episodes during the first year after transplantation was less frequent among recipients receiving MMF compared to those treated with azathioprine. The overall 5-year survivals for patients was 86.29% and for grafts 74.04%. CONCLUSION: Cyclosporine remains a useful immunosuppressive drug, which represents a major step toward efficient renal transplantation. The availability of multiple effective immunosuppressive agents allows individualized protocols to reduce toxic effects. The advent of new induction regimens offers more opportunities to prolong graft life.


Subject(s)
Cyclosporine/therapeutic use , Kidney Transplantation/immunology , Adult , Child , Drug Therapy, Combination , Graft Survival/drug effects , Graft Survival/immunology , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/mortality , Kidney Transplantation/physiology , Retrospective Studies , Survival Analysis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL